Clinical Trial Update: Safety Study Providing 12 Months Follow-up From First Exposure to HP802-247 in Subjects With Venous Leg Ulcer

View source ↗

Summary

This safety study update provides 12 months of follow-up data from the first exposure to HP802-247 in subjects with venous leg ulcers, with the study status cur…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Venous Leg Ulcer

Drugs mentioned

• hp802-247

Snippet

Sponsor: Healthpoint | Conditions: Venous Leg Ulcer | Status: UNKNOWN